4-(CYCLOPROPYLMETHOXY)-2-FLUOROBENZOIC ACID, 95.0%, 2g

Ethyl 2-(naphthalen-1-yloxy)acetate, 98%, 1g

(S)-1-(3-(Trifluoromethyl)phenyl)ethanamine, 95.0%, 1g

4-[7,12,17-tris(4-chlorophenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1�,?.1?,��.1��,�?]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaen-2-yl]phenol, 95%, 50mg

(R)-1-(TERT-BUTOXYCARBONYL)-4,4-DIMETHYLPYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 500mg

1,2,3,5,6-Pentathiepane, 95.0%, 10g

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 25 ml, 10/19, 2 Pieza(s)

(4-methoxybenzyl)(1-naphthylmethyl)amine hydrobromide, 95.0%, 1g

N-methyl-2-(2-methylpiperidin-1-yl)ethanamine, 95.0%, 1g

6-(2-FLUOROPYRIDIN-3-YL)-9-(TETRAHYDRO-2H-PYRAN-2-YL)-9H-PURINE, 95.0%, 100mg

5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one, 95.0%, 5mg

Ethyl 2-Amino-3,5-dibromobenzoate, 5g

Ocular EWF 10x/20 mm con aguja apuntadora, tubo de Ø 23,2 mm